Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
miROI Study
NCT04009733Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2019
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: micro Ribonucleic Acids (miRs) expression in serum at 1 month. Started Oct 2019; status: completed.
Beyond the preview
Go deeper on NCT04009733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009733.